Alliance Pharma plc Stock

Equities

APH

GB0031030819

Pharmaceuticals

Market Closed - London S.E. 11:35:16 2024-05-30 am EDT 5-day change 1st Jan Change
39.1 GBX +2.89% Intraday chart for Alliance Pharma plc +1.30% -3.46%
Sales 2023 * 183M 233M Sales 2024 * 196M 250M Capitalization 205M 261M
Net income 2023 * 17M 21.63M Net income 2024 * 18M 22.9M EV / Sales 2023 * 1.63 x
Net Debt 2023 * 92.2M 117M Net Debt 2024 * 69.1M 87.91M EV / Sales 2024 * 1.4 x
P/E ratio 2023 *
11.5 x
P/E ratio 2024 *
11.6 x
Employees 285
Yield 2023 *
2.66%
Yield 2024 *
2.72%
Free-Float 88.24%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.18%
1 week-0.39%
Current month+13.09%
1 month+13.09%
3 months-7.90%
6 months-0.77%
Current year-5.06%
More quotes
1 week
37.00
Extreme 37
41.00
1 month
24.55
Extreme 24.55
41.70
Current year
24.55
Extreme 24.55
46.00
1 year
24.55
Extreme 24.55
62.60
3 years
24.55
Extreme 24.55
123.00
5 years
24.55
Extreme 24.55
123.00
10 years
24.55
Extreme 24.55
123.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO 58 15-09-27
Chief Operating Officer - 23-01-31
Chief Tech/Sci/R&D Officer 56 12-12-31
Members of the board TitleAgeSince
Director/Board Member 49 10-02-21
Director/Board Member 55 23-01-31
Director/Board Member 58 18-12-31
More insiders
Date Price Change Volume
24-05-30 39.1 +2.89% 665 190
24-05-29 38 -1.68% 1,578,851
24-05-28 38.65 -3.38% 2,333,541
24-05-24 40 +3.63% 3,478,382
24-05-23 38.6 +9.82% 4,416,310

Delayed Quote London S.E., May 30, 2024 at 08:29 am EDT

More quotes
Alliance Pharma plc is a United Kingdom-based consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. The Company's segments are strategic business units that represent different parts of the overall product portfolio, these being Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Changmin, Fazol Cream, Hydromol Ointment, Kelo-Stretch Cream, and others. It holds the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are sold around the world in more than 100 countries.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.38 GBP
Average target price
0.6529 GBP
Spread / Average Target
+71.81%
Consensus

Quarterly revenue - Rate of surprise